News and Info

Welcome to the News and Information section of the ECOG-ACRIN Cancer Research Group website. The materials posted in this section are intended to keep constituents informed of the latest news and activities of the organization. The information below includes press releases, announcements, media advisories, and links to news articles.

We welcome inquiries from members of the press regarding the information posted on this website. To place a media inquiry, contact the Office of Communications.


Latest News

January 6, 2025

Can we omit stem cell transplants in patients with mantle cell lymphoma with undetectable residual disease? (features EA4151)

January 5, 2025

NCI’s myeloMATCH precision medicine initiative pushes the envelop in myeloid leukemia care

January 3, 2025

WATCH: Dr. Efrat Dotan on pancreatic cancer in older adults (features EA2186/GIANT)

January 3, 2025

A delicate balance: Treating older patients with metastatic pancreas cancer (with EA2186/GIANT trial chair Efrat Dotan)

December 18, 2024

How ECOG-ACRIN and Caris Life Sciences are teaming up to fight cancer

December 13, 2024

Tamoxifen cuts 15-year recurrence in DCIS without radiation therapy

December 12, 2024

Press Release: Adjuvant tamoxifen may reduce recurrence risk for patients with ‘good-risk’ DCIS who forgo radiation

December 11, 2024

Does acalabrutinib fit into frontline therapy for patients with mantle cell lymphoma? (Study EA4181)

December 10, 2024

Press Release: Autologous stem cell transplants do not improve survival for mantle cell lymphoma patients with undetectable MRD, clinical trial shows

December 4, 2024

Upfront treatment and early intervention to get attention at ASH 2024, including mantle cell lymphoma with the striking results of study EA4151

November 26, 2024

WATCH: David Schiff discusses the striking survival improvement for patients with low-grade brain tumors found in study E3F05

November 26, 2024

The November 2024 News from ECOG-ACRIN blog is now available

November 25, 2024

Press Release: Clinical trial finds that adding the chemotherapy pill temozolomide to radiation therapy improves survival in adult patients with a slow-growing type of brain tumor

November 25, 2024

Press Release: ECOG-ACRIN adds a late-breaking abstract to its ASH 2024 presentation line-up

November 22, 2024

Press Release: ECOG-ACRIN appoints seven researchers to scientific committee leadership positions

October 30, 2024

ECOG-ACRIN and Caris partner to learn more from the TAILORx trial

October 30, 2024

Using the geriatric assessment to actualize goal-concordant care (with EA2186/GIANT study chair Dr. Efrat Dotan)

October 30, 2024

WATCH: Behind the ECOG-ACRIN E1910 trial with lead investigator Dr. Mark Litzow

October 29, 2024

WATCH: Breast Cancer Research Foundation hosts Dr. Joseph Sparano and Amanda Quick of The Pink Agenda to discuss metastatic breast cancer

October 25, 2024

ECOG-ACRIN Lymphoma Committee co-chair Andrew Evens comments on the results of the SWOG study S1826, Nivolumab-AVD in Advanced-Stage Classic Hodgkin Lymphoma

 
ECOG-ACRIN Cancer Research Group